Trial Profile
Prospective study of the prescription of anidulafungin for serious intra-abdominal infections hospitalized in resuscitation
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 23 Jan 2017
Price :
$35
*
At a glance
- Drugs Anidulafungin (Primary)
- Indications Candidiasis; Intra-abdominal infections
- Focus Adverse reactions; Therapeutic Use
- 23 Jan 2017 New trial record
- 14 Jan 2017 Results (n=14) published in the Journal of Antimicrobial Chemotherapy